Fig. 4
Weight lowering efficacy of gliclazide MR stratified according to calculated baseline body mass index (BMI). n = 838 for the “18.5–24.9 kg/m2” group; n = 3029 for the “25.0 to < 30 kg/m2” group; and n = 3191 for the “ ≥ 30 kg/m2” group. *P = 0.02 and †P < 0.001 for the difference between corresponding baseline and month 6 weights. BMI data are presented as mean (SD)